StoxGud Sign in
40

Vijaypd Ceutical Limited

NSE: VIJAYPD · Unclassified

₹77.50-0.96%06 Nov 2026

Ask the data

Instant answers about Vijaypd Ceutical Limited — computed from its filings, no language model
Market cap₹151 cr
Current price₹77.50
High / Low₹109 / ₹36
P/E30.3
P/B2.88
Book value₹26.9
ROE9.5%
ROCE9.1%
Debt / equity0.70
Dividend yield—
EPS (TTM)₹2.56
Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin
FY26
Revenue100.2
EBITDA4.7
Operating margin4.7%
Interest1.7
Depreciation0.7
Profit before tax6.5
Tax1.5
Net profit5.0
EPS ₹3.00
Operating cash flow-8.8
Capex2.7
Dividend paid0.0
Total assets100.7
Equity52.5

Half-yearly performance

last 2 half years · ₹ crore
H1 FY26*H2 FY26
Revenue100.20.0
Operating profit4.70.0
Operating margin4.7%—
Other income4.10.0
Interest1.70.0
Depreciation0.70.0
Profit before tax6.50.0
Tax1.50.0
Net profit5.00.0
EPS ₹3.000.00

Returns & margins

trailing-twelve-month, per half year
H2 FY26
ROE9.5%
ROCE9.1%
Net margin5.0%
EBITDA margin4.7%
Debt / equity0.70
Interest coverage4.90
Asset turnover1.00

Balance sheet

equity vs borrowings over time · ₹ crore
MAR '26
Share capital19.5
Other equity / reserves33.0
Total equity52.5
Borrowings36.7
Current liabilities43.3
Non-current liabilities5.0
Total assets100.7
Property, plant & equipment5.2
Investments0.3
Inventories12.5
Receivables31.6
Cash & equivalents17.5

Cash flow

annual · ₹ crore · line = free cash flow
FY26
Cash from operations-8.8
Cash from investing-13.3
Cash from financing28.2
Capex2.7
Free cash flow-11.4
Dividends paid0.0

Where the assets sit

Mar '26 · ₹ crore
Fixed assets (PPE)
₹5.2 cr5%
Investments
₹0.3 cr0%
Inventories
₹12.5 cr12%
Receivables
₹31.6 cr31%
Cash & equivalents
₹17.5 cr17%
Other assets
₹33.6 cr33%

Peer comparison

largest in Unclassified · this company in bold
CompanyMarket cap ₹crPriceP/EP/BROE
Avantel Limited36,86,04,549138.69—1059360.680.0%
Ducol Organics And Colours Limited19,55,275120.00—20089.130.0%
Jio Platforms Limited12,57,1811,406.40—3.57—
SBI Funds Management Limited1,01,750499.55———
Tamilnadu Telecommunication Limited91,3149.93———
Manipal Health Enterprises Limited76,294646.70———
INDO-MIM Limited59,0421,219.50———
AvenuesAI Limited45,138129.25153.69.516.2%
Dhoot Transmission Limited32,7611,601.60—8.11—
3M India Limited31,07127,570.0053.817.5732.7%
Vijaypd Ceutical Limited15177.5030.32.889.5%

StoxGud checklist: Neutral setup · 4/10

  • Price above 50-day average
  • Price above 200-day average
  • 50-day average above 200-day (uptrend)
  • RSI in healthy 40–70 zone
  • Positive 1-year return
  • Return on equity above 15%
  • Debt to equity below 1
  • Revenue growing year on year
  • Net profit margin above 10%
  • P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-7.4%
6 months-17.9%
1 year—
3Y CAGR—
5Y CAGR—
10Y CAGR—
50-day avg₹73.87
200-day avg₹71.17
RSI (14)37

FAQs

What is the share price of Vijaypd Ceutical Limited?

Vijaypd Ceutical Limited (VIJAYPD) closed at ₹77.50 on NSE on 06 Nov 2026.

What is the market cap of Vijaypd Ceutical Limited?

₹151 crore at the latest close.

What is the P/E ratio of Vijaypd Ceutical Limited?

30.3, on trailing-twelve-month earnings from its filings.

How fast is Vijaypd Ceutical Limited growing?

Not enough filed history yet to measure Vijaypd Ceutical Limited's growth.

How profitable is Vijaypd Ceutical Limited?

On a trailing-twelve-month basis return on equity is 9.5%, return on capital employed 9.1%, operating margin 4.7%, net margin 5.0%.

How much debt does Vijaypd Ceutical Limited have?

Vijaypd Ceutical Limited is moderately geared: debt to equity is 0.70 with borrowings of ₹37 cr against cash of ₹18 cr (balance sheet of 2026-03-31). Operating profit covers interest 4.9 times.

Financials parsed from Vijaypd Ceutical Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Half-yearly from H1 FY26, annual from FY26, balance sheet from Mar '26. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.